NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/14/2023
Back to search
Official data from USPTO
CTI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
07/14/2023
Trademark type
Word
Nice classes
5
Filing date
03/28/2002
Registration date
01/14/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/13/2023
Last transaction
07/13/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
05/20/1993
First use in commerce
05/20/1993
Drawing code
1
Owner type
03
Owner location
SEATTLE, WA
Examiner
SOUDERS, MICHAEL
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
CTI BIOPHARMA CORP.
Cell Therapeutics, Inc.
Representatives
Frances M. Jagla CHRISTENSEN O'CONNOR JOHNSON KINDNESS PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations used for the treatment of cancer; and pharmaceutical preparations used for the treatment of immunological and inflammatory diseasesinfections secondary to the oncologic diseasethe management of pain accompanying either the disease process or the associated treatment regimens
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/13/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/13/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/13/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
12/19/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/14/2022
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
06/12/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/14/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/14/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/14/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/14/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/14/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/02/2014
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/18/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/18/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/18/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/18/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
04/03/2013
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
01/16/2009
ES8R
TEAS SECTION 8 RECEIVED
01/14/2009
CFIT
CASE FILE IN TICRS
08/26/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2003
PUBO
PUBLISHED FOR OPPOSITION
10/22/2002
NPUB
NOTICE OF PUBLICATION
10/02/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2002
DOCK
ASSIGNED TO EXAMINER
07/30/2002
DOCK
ASSIGNED TO EXAMINER
07/26/2002
Continuous trademark protection
Get notified about every new filing that threatens CTI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.